Biohaven licenses pan-IgG degraders to Ono for $80M; UK pulls Ixchiq; ADC raises $86.6M; BMS Zenbexus Phase 3 win; Pfizer ...
WHO releases preeclampsia roadmap; Comanche, DiaMedica, Avilar & ProFound developing treatments; Eli Lilly exploring the ...
Grindr acquires Freddie's parent for $250M to expand into HIV prevention (PrEP). The company will combine that with ED drugs and GLP-1s under new Grindr Health brand.
Petrelintide reduced patients’ average body weight by up to 9.2%, compared to 2.0% among those who received placebo.
Roche partners with Hangzhou-based Defand Therapeutics in a ~$1B deal, under $10M upfront, to develop molecular glue ...
General Medicine raises a $120M Series B led by a16z, betting its 2,900-product catalog can serve AI shopping agents as well as people.
Chan Zuckerberg Biohub launches $1.8B Virtual Biology Initiative with Meta, Google DeepMind, Isomorphic Labs, DOE, and NIH to ...
Ultragenyx sells a rare pediatric disease PRV for $210M, one of 2026's priciest voucher deals, and plans to monetize a second ...
The World Health Organization on Wednesday recommended against GLP-1 drugs for children with obesity who are under 10 and ...
PhRMA sued CMS over GLOBE, the Trump admin's Medicare Part B demo tying drug prices to overseas rates, calling it unlawful.
The court ruled that Merck infringed one of Halozyme's patents and granted an injunction that bars Merck from marketing subcutaneous Keytruda in Belgium, Denmark, France, Ireland, Italy, Sweden, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results